Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Lyell Immunopharma

Hematology

Hematology Today—February 16, 2026

This weekly Hematology update covers key developments including late-stage…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - September 11th 2025

Gene & Cell Therapy Update: Lilly Obesity Deal, RMAT for Stargardt, XLRP…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026
AI in Healthcare and Digital Health Today—March 23, 2026

Tags

AI in neurology Alzheimer’s blood test american medical association Amylin therapy Arcutis arrhythmias Atalante X beacon biosignals Biktarvy biomarin pharmaceutical clinical validation Drug discovery AI Dual agonist therapy EASD25 ESC Digital & AI Summit GM1 gangliosidosis Huons IAS 2025 ITM Isotope Technologies Munich ivc thrombectomy lunit mavacamten measurable residual disease OBODENCE OCRA OCT imaging PCSK9 inhibitor Pediatric-onset MS perioperative therapy Pluristyx Pulmonary vascular disease Quotient Therapeutics rosacea Rubraca SABCS Sequoia Capital SkinVision Stem-cell diabetes therapy T-cell engager TB integration tenaya therapeutics Urothelial carcinoma Usher syndrome type 1B UTOpia bioartificial liver Zika vaccine

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026
AI in Healthcare and Digital Health Today—March 23, 2026

TAGS

AI in neurology Alzheimer’s blood test american medical association Amylin therapy Arcutis arrhythmias Atalante X beacon biosignals Biktarvy biomarin pharmaceutical clinical validation Drug discovery AI Dual agonist therapy EASD25 ESC Digital & AI Summit GM1 gangliosidosis Huons IAS 2025 ITM Isotope Technologies Munich ivc thrombectomy lunit mavacamten measurable residual disease OBODENCE OCRA OCT imaging PCSK9 inhibitor Pediatric-onset MS perioperative therapy Pluristyx Pulmonary vascular disease Quotient Therapeutics rosacea Rubraca SABCS Sequoia Capital SkinVision Stem-cell diabetes therapy T-cell engager TB integration tenaya therapeutics Urothelial carcinoma Usher syndrome type 1B UTOpia bioartificial liver Zika vaccine

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy